|
|
|
Volumn 2, Issue 3, 2002, Pages 244-245
|
|
Phase II clinical trial of XYOTAX in non-small cell lung cancer to continue.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG DERIVATIVE;
PACLITAXEL;
POLYGLUTAMIC ACID;
POLYGLUTAMIC ACID PACLITAXEL;
POLYGLUTAMIC ACID-PACLITAXEL;
TAXOID;
ARTICLE;
DRUG TOLERANCE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
PHASE 2 CLINICAL TRIAL;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II;
DRUG TOLERANCE;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
POLYGLUTAMIC ACID;
TAXOIDS;
|
|
EID: 0036594187
PISSN: 14737140
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|